Drupal.behaviors.print = function(context) {window.print();window.close();}>
Alnylam Names Hemophilia Drug as Newest Pipeline Candidate
September 08, 2011
Alnylam Names Hemophilia Drug as Newest Pipeline Candidate
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Alnylam Adds New Program to Pipeline as It Shelves Anemia Candidate
January 10, 2013 / Gene Silencing News
Alnylam Selects Hemophilia Candidate, Releases Preclinical Data
July 12, 2012 / Gene Silencing News
Alnylam Focuses on Two Lead Programs, Won't Advance Others without Partners
January 12, 2012 / Gene Silencing News
UMass, Other Defendants Seek Dismissal of University of Utah Tuschl-II IP Lawsuit
November 3, 2011 / Gene Silencing News
Amid Delivery Tech Dispute, Alnylam Forges Collaboration with Precision NanoSystems
April 21, 2011 / Gene Silencing News